Incidental Mutation 'R5415:Drd2'
ID |
501037 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Drd2
|
Ensembl Gene |
ENSMUSG00000032259 |
Gene Name |
dopamine receptor D2 |
Synonyms |
D2R, D2 receptor, Drd-2 |
MMRRC Submission |
042984-MU
|
Accession Numbers |
|
Essential gene? |
Possibly non essential
(E-score: 0.452)
|
Stock # |
R5415 (G1)
|
Quality Score |
225 |
Status
|
Not validated
|
Chromosome |
9 |
Chromosomal Location |
49251927-49319477 bp(+) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
A to G
at 49313553 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Lysine to Glutamic Acid
at position 241
(K241E)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000075170
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000075764]
|
AlphaFold |
P61168 |
Predicted Effect |
possibly damaging
Transcript: ENSMUST00000075764
AA Change: K241E
PolyPhen 2
Score 0.810 (Sensitivity: 0.84; Specificity: 0.93)
|
SMART Domains |
Protein: ENSMUSP00000075170 Gene: ENSMUSG00000032259 AA Change: K241E
Domain | Start | End | E-Value | Type |
Pfam:7TM_GPCR_Srsx
|
45 |
238 |
2.5e-15 |
PFAM |
Pfam:7tm_1
|
51 |
427 |
1.2e-88 |
PFAM |
|
Coding Region Coverage |
- 1x: 99.2%
- 3x: 98.5%
- 10x: 96.9%
- 20x: 94.2%
|
Validation Efficiency |
|
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. [provided by RefSeq, Jul 2008] PHENOTYPE: Homozygous null mice show Parkinson's disease like symptoms, including akinetic and bradykinetic behavior. Mice lacking only the long isoform are hypoactive and exhibit increased sterotypic behavior in response to dopamine agonists. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 39 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
Arhgef18 |
G |
A |
8: 3,438,075 (GRCm39) |
R303H |
probably damaging |
Het |
Ark2c |
C |
A |
18: 77,554,435 (GRCm39) |
V60L |
probably damaging |
Het |
Asb15 |
A |
T |
6: 24,570,690 (GRCm39) |
Q556L |
probably benign |
Het |
Ccr1 |
G |
T |
9: 123,764,413 (GRCm39) |
P39H |
probably damaging |
Het |
Cd177 |
A |
T |
7: 24,451,816 (GRCm39) |
L400Q |
probably damaging |
Het |
Cfap298 |
G |
T |
16: 90,722,953 (GRCm39) |
D260E |
probably benign |
Het |
Cideb |
T |
C |
14: 55,995,312 (GRCm39) |
E58G |
probably damaging |
Het |
Ect2 |
C |
T |
3: 27,201,002 (GRCm39) |
C126Y |
probably damaging |
Het |
Eef1d |
T |
C |
15: 75,775,030 (GRCm39) |
T210A |
probably benign |
Het |
Enpp2 |
G |
A |
15: 54,745,552 (GRCm39) |
H315Y |
probably damaging |
Het |
Ero1b |
A |
T |
13: 12,616,656 (GRCm39) |
M362L |
probably benign |
Het |
Exosc2 |
A |
G |
2: 31,562,578 (GRCm39) |
K73E |
possibly damaging |
Het |
Gm9637 |
T |
A |
14: 19,402,143 (GRCm38) |
|
noncoding transcript |
Het |
Gstm5 |
A |
G |
3: 107,804,811 (GRCm39) |
D101G |
probably damaging |
Het |
Igkv4-80 |
A |
C |
6: 68,993,649 (GRCm39) |
S81A |
probably benign |
Het |
Kmt2c |
T |
C |
5: 25,519,699 (GRCm39) |
D2137G |
probably benign |
Het |
Mecom |
T |
C |
3: 30,011,675 (GRCm39) |
D619G |
possibly damaging |
Het |
Met |
A |
G |
6: 17,527,084 (GRCm39) |
I512V |
probably benign |
Het |
Myh15 |
A |
G |
16: 48,937,658 (GRCm39) |
K753R |
probably null |
Het |
Nfatc4 |
A |
G |
14: 56,070,091 (GRCm39) |
D753G |
probably benign |
Het |
Or2l5 |
T |
A |
16: 19,333,996 (GRCm39) |
H130L |
possibly damaging |
Het |
Or4c113 |
T |
A |
2: 88,885,240 (GRCm39) |
T177S |
probably benign |
Het |
Or4c12 |
T |
A |
2: 89,773,731 (GRCm39) |
T243S |
probably benign |
Het |
Otx1 |
C |
A |
11: 21,947,037 (GRCm39) |
A91S |
probably damaging |
Het |
Parp9 |
C |
T |
16: 35,763,752 (GRCm39) |
A10V |
probably damaging |
Het |
Pcdh8 |
C |
A |
14: 80,007,688 (GRCm39) |
E292* |
probably null |
Het |
Pdpn |
A |
T |
4: 142,995,788 (GRCm39) |
V161D |
probably damaging |
Het |
Peg3 |
A |
G |
7: 6,711,628 (GRCm39) |
V1198A |
probably benign |
Het |
Phykpl |
T |
C |
11: 51,476,342 (GRCm39) |
S21P |
probably benign |
Het |
Plcb1 |
G |
T |
2: 135,189,322 (GRCm39) |
V817F |
possibly damaging |
Het |
Polk |
T |
C |
13: 96,620,463 (GRCm39) |
Y579C |
probably benign |
Het |
Ppp1r18 |
A |
G |
17: 36,178,511 (GRCm39) |
N129D |
probably benign |
Het |
Psg29 |
C |
A |
7: 16,945,561 (GRCm39) |
|
probably null |
Het |
Rims4 |
C |
T |
2: 163,760,596 (GRCm39) |
R3H |
probably benign |
Het |
Rps6kl1 |
A |
T |
12: 85,186,155 (GRCm39) |
C292S |
probably benign |
Het |
Uaca |
G |
T |
9: 60,777,421 (GRCm39) |
G603C |
possibly damaging |
Het |
Vmn1r60 |
T |
C |
7: 5,547,416 (GRCm39) |
H228R |
probably benign |
Het |
Vmn2r7 |
T |
C |
3: 64,623,658 (GRCm39) |
T221A |
probably benign |
Het |
Zfp647 |
C |
A |
15: 76,795,593 (GRCm39) |
V356L |
possibly damaging |
Het |
|
Other mutations in Drd2 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL00423:Drd2
|
APN |
9 |
49,307,058 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL01407:Drd2
|
APN |
9 |
49,312,115 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL01669:Drd2
|
APN |
9 |
49,313,389 (GRCm39) |
missense |
possibly damaging |
0.90 |
IGL02011:Drd2
|
APN |
9 |
49,318,258 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL02417:Drd2
|
APN |
9 |
49,313,559 (GRCm39) |
splice site |
probably benign |
|
R0374:Drd2
|
UTSW |
9 |
49,311,084 (GRCm39) |
missense |
probably benign |
0.41 |
R0402:Drd2
|
UTSW |
9 |
49,316,271 (GRCm39) |
missense |
probably benign |
0.00 |
R0529:Drd2
|
UTSW |
9 |
49,318,374 (GRCm39) |
missense |
probably benign |
|
R1124:Drd2
|
UTSW |
9 |
49,306,940 (GRCm39) |
missense |
probably damaging |
0.98 |
R1458:Drd2
|
UTSW |
9 |
49,313,512 (GRCm39) |
missense |
probably damaging |
1.00 |
R1807:Drd2
|
UTSW |
9 |
49,316,367 (GRCm39) |
missense |
probably damaging |
1.00 |
R1888:Drd2
|
UTSW |
9 |
49,313,442 (GRCm39) |
missense |
probably benign |
0.05 |
R1888:Drd2
|
UTSW |
9 |
49,313,442 (GRCm39) |
missense |
probably benign |
0.05 |
R1971:Drd2
|
UTSW |
9 |
49,318,359 (GRCm39) |
missense |
probably damaging |
1.00 |
R2192:Drd2
|
UTSW |
9 |
49,314,571 (GRCm39) |
missense |
probably benign |
0.03 |
R2218:Drd2
|
UTSW |
9 |
49,311,094 (GRCm39) |
missense |
probably damaging |
1.00 |
R3830:Drd2
|
UTSW |
9 |
49,313,443 (GRCm39) |
missense |
probably damaging |
0.99 |
R4214:Drd2
|
UTSW |
9 |
49,316,221 (GRCm39) |
missense |
probably benign |
0.00 |
R4595:Drd2
|
UTSW |
9 |
49,316,089 (GRCm39) |
missense |
probably benign |
0.03 |
R5392:Drd2
|
UTSW |
9 |
49,306,928 (GRCm39) |
missense |
possibly damaging |
0.80 |
R5598:Drd2
|
UTSW |
9 |
49,318,315 (GRCm39) |
missense |
possibly damaging |
0.94 |
R5646:Drd2
|
UTSW |
9 |
49,316,212 (GRCm39) |
missense |
probably benign |
|
R5715:Drd2
|
UTSW |
9 |
49,316,189 (GRCm39) |
missense |
probably benign |
0.00 |
R5901:Drd2
|
UTSW |
9 |
49,318,259 (GRCm39) |
nonsense |
probably null |
|
R6365:Drd2
|
UTSW |
9 |
49,318,249 (GRCm39) |
missense |
probably damaging |
1.00 |
R6748:Drd2
|
UTSW |
9 |
49,314,502 (GRCm39) |
nonsense |
probably null |
|
R7017:Drd2
|
UTSW |
9 |
49,312,129 (GRCm39) |
missense |
probably benign |
0.32 |
R7754:Drd2
|
UTSW |
9 |
49,316,277 (GRCm39) |
missense |
probably benign |
|
R9092:Drd2
|
UTSW |
9 |
49,307,004 (GRCm39) |
missense |
probably benign |
|
R9444:Drd2
|
UTSW |
9 |
49,318,347 (GRCm39) |
missense |
probably damaging |
1.00 |
R9488:Drd2
|
UTSW |
9 |
49,311,094 (GRCm39) |
missense |
probably damaging |
1.00 |
X0022:Drd2
|
UTSW |
9 |
49,312,081 (GRCm39) |
missense |
probably damaging |
1.00 |
Z1176:Drd2
|
UTSW |
9 |
49,306,955 (GRCm39) |
nonsense |
probably null |
|
|
Predicted Primers |
PCR Primer
(F):5'- GTGTATCATTGCCAACCCTGC -3'
(R):5'- GATCTTCACATGGCGAATCCTAC -3'
Sequencing Primer
(F):5'- CAACCCTGCCTTCGTGG -3'
(R):5'- ACATGGCGAATCCTACTTAGCTC -3'
|
Posted On |
2017-12-01 |